Evidence map›Paper›PMID 37749369›Full record

ArticleScientific reports2023

Glucagon-like peptide-1 and glucagon-like peptide-2 regulation during human liver regeneration.

Markus Ammann, Jonas Santol, David Pereyra, Tamara Kalchbrenner, Tanja Wuerger, Johannes Laengle, Rory L Smoot, Wolfgang Hulla, Friedrich Laengle, Patrick Starlinger

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Lipid regulation of the glucagon receptor family.The Journal of endocrinology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Markus AmmannDepartment of Surgery, State Hospital Wiener Neustadt, Wiener Neustadt, Austria.
Jonas SantolDepartment of Surgery, HPB Centre, Viennese Health Network, Clinic Favoriten and Sigmund Freud Private University, Vienna, Austria.
David PereyraDivision of Visceral Surgery, Department of General Surgery, Medical University of Vienna, Vienna, Austria.
Tamara KalchbrennerDepartment of Pathology, State Hospital Wiener Neustadt, Wiener Neustadt, Austria.
Tanja WuergerDepartment of Pathology, State Hospital Wiener Neustadt, Wiener Neustadt, Austria.
Johannes LaengleDivision of Visceral Surgery, Department of General Surgery, Medical University of Vienna, Vienna, Austria.
Rory L SmootDepartment of Surgery, Division of Hepatobiliary and Pancreas Surgery, Mayo Clinic, 200 First Street SW, Rochester, MN, USA.
Wolfgang HullaDepartment of Pathology, State Hospital Wiener Neustadt, Wiener Neustadt, Austria.
Friedrich LaengleDepartment of Surgery, State Hospital Wiener Neustadt, Wiener Neustadt, Austria.
Patrick StarlingerDivision of Visceral Surgery, Department of General Surgery, Medical University of Vienna, Vienna, Austria. starlinger.patrick@mayo.edu.
Fachhochschule Wiener Neustadt · ATMedical University of Vienna · ATMayo Clinic · USSigmund Freud University Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accumulating evidence suggests that metabolic demands of the regenerating liver are met via lipid metabolism and critical regulators of this process. As such, glucagon-like peptide-1 (GLP-1) and glucagon-like peptide-2 (GLP-2) critically affect hepatic regeneration in rodent models. The present study aimed to evaluate potential alterations and dynamics of circulating GLP-1 and GLP-2 in patients undergoing liver resections, focusing on post-hepatectomy liver failure (PHLF). GLP-1, GLP-2, Interleukin-6 (IL-6) and parameters of lipid metabolism were determined perioperatively in fasting plasma of 46 patients, who underwent liver resection. GLP-1 and GLP-2 demonstrated a rapid and consistently inverse time course during hepatic regeneration with a significant decrease of GLP-1 and increase of GLP-2 on POD1. Importantly, these postoperative dynamics were significantly more pronounced when PHLF occurred. Of note, the extent of resection or development of complications were not associated with these alterations. IL-6 mirrored the time course of GLP-2. Assessing the main degradation protein dipeptidyl peptidase 4 (DPP4) no significant association with either GLP-1 or -2 could be found. Additionally, in PHLF distinct postoperative declines in plasma lipid parameters were present and correlated with GLP-2 dynamics. Our data suggest dynamic inverse regulation of GLP-1 and GLP-2 during liver regeneration, rather caused by an increase in expression/release than by changes in degradation capacity and might be associated with inflammatory responses. Their close association with circulating markers of lipid metabolism and insufficient hepatic regeneration after liver surgery suggest a critical involvement during these processes in humans.

Indexed as

Hepatic InsufficiencyLiver FailureGlucagon-Like Peptide 1Glucagon-Like Peptide 2HepatectomyHumansInterleukin-6Liver RegenerationGlucagon-Like Peptide 1Glucagon-Like Peptide 2Interleukin-6

Identifiers

PMID37749369
PMCPMC10519971
OpenAlexW4387019476

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.